We are live on ! Find out more
P

Paradiem Portfolio holdings

AUM $464M
1-Year Est. Return 45.56%
This Fund
S&P 500
This Quarter Est. Return
+11%
1 Year Est. Return
+45.56%
3 Year Est. Return
+107.16%
5 Year Est. Return
+136.03%
10 Year Est. Return
AUM
$271M
AUM Growth
+$11.9M
Cap. Flow
-$8.95M
Cap. Flow %
-3.31%
Top 10 Hldgs %
21.05%
Holding
104
New
6
Increased
43
Reduced
37
Closed
10

Top Buys

Rank Stock Value
1
INGR icon
Ingredion
INGR
+$4.09M
2
PCAR icon
PACCAR
PCAR
+$4.09M
3
LTHM
Livent Corporation
LTHM
+$3.58M
4
DCGO icon
DocGo
DCGO
+$3.43M
5
CCRN
Cross Country Healthcare
CCRN
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 30.57%
2 Industrials 18.29%
3 Materials 9.65%
4 Healthcare 8.01%
5 Financials 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSCN
51
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$2.75M 1.02%
130,956
-11,230
-8% -$235K
WST icon
52
West Pharmaceutical
WST
$24B
$2.73M 1.01%
11,588
-133
-1% -$31.5K
WPC icon
53
W.P. Carey
WPC
$16.8B
$2.65M 0.98%
34,608
LEG icon
54
Leggett & Platt
LEG
$1.34B
$2.61M 0.96%
80,922
-38,343
-32% -$1.29M
LTHM
55
DELISTED
Livent Corporation
LTHM
$2.6M 0.96%
+130,911
New +$3.58M
TTD icon
56
Trade Desk
TTD
$8.48B
$2.6M 0.96%
57,998
-12,355
-18% -$626K
PWR icon
57
Quanta Services
PWR
$100B
$2.42M 0.9%
17,015
+546
+3% +$77.5K
REGN icon
58
Regeneron Pharmaceuticals
REGN
$78.5B
$2.42M 0.89%
3,350
-281
-8% -$207K
EGLE
59
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$2.38M 0.88%
47,657
-9,982
-17% -$501K
SNPS icon
60
Synopsys
SNPS
$74.4B
$2.34M 0.87%
7,342
+782
+12% +$245K
CF icon
61
CF Industries
CF
$19.2B
$2.25M 0.83%
26,461
-1,074
-4% -$109K
BSCO
62
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$2.21M 0.82%
108,121
-12,397
-10% -$253K
BSJO
63
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
$2.21M 0.82%
100,047
-9,166
-8% -$203K
PBR icon
64
Petrobras
PBR
$125B
$1.94M 0.72%
181,777
-65,314
-26% -$789K
HZNP
65
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.84M 0.68%
16,173
+2,644
+20% +$220K
AVTR icon
66
Avantor
AVTR
$9.32B
$1.81M 0.67%
86,042
-45,052
-34% -$933K
ENTG icon
67
Entegris
ENTG
$18.1B
$1.74M 0.64%
26,508
-8,318
-24% -$613K
AOSL icon
68
Alpha and Omega Semiconductor
AOSL
$950M
$1.72M 0.64%
60,321
-27,270
-31% -$882K
BSJN
69
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
$1.69M 0.63%
72,701
-7,342
-9% -$171K
CSCO icon
70
Cisco
CSCO
$457B
$1.69M 0.63%
35,543
MOS icon
71
The Mosaic Company
MOS
$7.03B
$1.66M 0.61%
37,898
-14,208
-27% -$703K
CCRN
72
DELISTED
Cross Country Healthcare
CCRN
$1.65M 0.61%
+62,277
New +$2.03M
MATX icon
73
Matsons
MATX
$6.13B
$1.45M 0.54%
23,177
-14,505
-38% -$958K
ASML icon
74
ASML
ASML
$626B
$1.38M 0.51%
2,526
+317
+14% +$166K
IBD icon
75
Inspire Corporate Bond ETF
IBD
$481M
$1.38M 0.51%
59,846
-2,639
-4% -$60.2K

Similar funds

Paradiem's Q4 2022 Portfolio in Review

As of Q4 2022, Paradiem held 104 positions worth $271M, up 4.6% from $259M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Paradiem withdrew a net $8.95M in Q4 2022, closing 10 positions and reducing 37 holdings. Its most notable exit was Lowe's Companies, an estimated $4.02M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Materials.

Against the trend, Paradiem opened a new position in Ingredion worth $4.35M.

  • Paradiem's largest Q4 2022 buy was Ingredion: 44,375 shares worth $4.35M.
  • Paradiem added most to Penguin Solutions Inc in Q4 2022, an estimated $965K increase.
  • Paradiem's biggest Q4 2022 reduction was Leggett & Platt, cutting an estimated $1.29M.
  • Paradiem fully exited Lowe's Companies in Q4 2022, selling an estimated $4.02M.
  • Paradiem's ten largest holdings make up 21% of its $271M portfolio in Q4 2022.
  • Paradiem opened 6 new positions and closed 10 in Q4 2022.
  • Paradiem's portfolio value rose 4.6% quarter-over-quarter to $271M.

Based on Paradiem's 13F filing for Q4 2022, filed 24 Jan 2023.